Apixaban 2.5 mg twice daily is effective and safe for patients with atrial fibrillation and combinations of advanced age, low body weight, and elevated creatinine: insights from ARISTOTLE
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Pitie Salpetriere APHP University Hospital, Paris (France)
13 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
You may be interested in
Congress Session
Congress Session
